Q1 earnings reports from major U.S. health insurers reveal volatile market dynamics driven by Medicare Advantage payment changes and diverse strategic challenges. Insight into implications for providers, payers, and policy.

Explore CMS's FY 2026 proposed Medicare IPPS rule detailing hospital payment increases, uncompensated care funding, quality program updates, and regulatory streamlining affecting hospital reimbursement and compliance for 2025-26.

CMS's 2026 Final Rule implements the Medicare Drug Price Negotiation Program with the Medicare Transaction Facilitator, affecting Part D drug pricing and pharmacy reimbursement processes.

Washington Senate approves SB5721 to mandate appraisal rights in auto insurance claims, enhancing policyholder dispute resolution. Bill awaits governor's signature.